Abstract:Objective To observe the effects of three treatment methods on renal anemia in maintenance hemodialysis patients with hyperparathyroidism secondary to uremia and analyze the influencing factors of erythropoietin (EPO) dosage. Methods A total of 55 maintenance hemodialysis patients with secondary hyperparathyroidism at the hemodialysis center of Huashan Hospital affiliated to Fudan University from January 2015 to December 2016 were retrospectively divided into three groups according to different treatment methods, parathyroidectomy +forearm transplantation group (surgery group, n=16), cinacalcet treatment group (n=6), and calcitriol treatment group (n=33), respectively. The hemoglobin level and erythropoietin dosage were measured before treatment and in the 3rd month, the 6th month and the 12th month after treatment. The changes of hemoglobin and erythropoietin dosage in the three groups before and after treatment were observed, and the mixed effect model was used to analyze the difference of the change of hemoglobin and erythropoietin dosage among three groups. Multiple linear regression analysis was used to analyze the influencing factors of EPO dosage after one year. Results The levels of intact parathyroid hormone (iPTH) in the surgery group and the cinacalcet group before treatment were significantly higher than that in the calcitriol group (both P<0.05). In the 12th month after treatment, the levels of iPTH decreased significantly in the patients of surgery group and the cinacalcet group compared with those before treatment (both P<0.05). The levels of serum alkaline phosphatase, serum calcium and serum phosphorus in the surgery group also decreased significantly compared with those before treatment (all P<0.05). The mixed effect model analysis showed that the hemoglobin level of surgery group was on an upward trend after the treatment, and the overall level was significantly higher than cinacalcet and calcitriol treatment group (P=0.007). There was no significant difference in the dosage change of erythropoietin (EPO) in the three groups over time. However, the intra-group comparison of the mixed effect model showed that the dosage of EPO in the 12th month was significantly lower than that of before the treatment in surgery group (P=0.007). Multiple linear regression analysis showed that dialysis vintage (B=-0.064, P=0.012) and ferritin ≥ 500 μg/L (B=0.645, P=0.032) were independent influencing factors of EPO dosage. The longer the dialysis vintage, the less EPO dosage, and more EPO dosage were observed in patients with ferritin ≥ 500 μg/L. Conclusions Parathyroidectomy and forearm transplantation is more effective in reducing EPO dosage and improving renal anemia in maintenance hemodialysis patients with secondary hyperparathyroidism. Dialysis vintage and ferritin are independent influencing factors for the dosage of EPO.

Parathyroid Hormone Clearance Effect in Uremic Patients by Hemoperfusion with Different Blood Flow Rate

The Design and Clinical Application of a New Type of Disposable Heparin Free Dialysis Tube

Clinical Observation of Improving Uremia Combined with Hyperparathyroidism by Treatment of Hemoperfusion Series Coupling Hemodiafiltration

Effect of parathyroid hormone on myocardial damage,cardiac structure and function in maintenance hemodialysis patients

Cleanrance of serum leptin and parathyroid hormone in patients undergoing hemoperfusion and hemodiafiltration

Effect of Parathyroidectomy on Anemia and Cardiac Function in Uremic Patients with Secondary Hyperparathyroidism

Effect of hemodialysis combined with hemoperfusion on secondary hyperparathyroidism in uremia

Effects of different combinations of artificial kidney treatments for bone and mineral metabolism in patients with maintenance hemodialysis

Different Ways in Flux Hemodialysis Treatment of Uremic Patients Compared

Timing of Hemoperfusion During Combined Treatment with Hemodialysis and Hemoperfusion

Preventim and treatment of uremia accompanied by vascular calcification by hemoperfusion combined with hemodialysis-filtration

Primary Clinical Experience in High Risk Uremic Patients Converted from Conventional to Short Daily Hemodialysis

Curative Effect of High Flux Dialysis on Hyperphosphatemia

Clinical observation of low molecular weight heparin on calcium-phosphate metabolism in maintenance hemodialysis patients

Influence of different combinations of hemopurification methods on mineral and bone metabolism in he-modialysis patients

Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients

The design and effects of parallel double venous pots hemodialysis tubing set

Effects of calcitriol pulse therapy in patients with secondary hyperparathyroidism undergoing hemodialysis

Effects of different treatment methods on renal anemia in maintenance hemodialysis patients with hyperparathyroidism secondary to uremia

Effects of Parathyroidectomy on Renal Anemia in Maintenance Hemodialysis Patients with Severe Secondary Hyperparathyroidism

Combination of Maintenance Hemodialysis with Hemoperfusion: A Safe and Effective Model of Artificial Kidney